Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma; results of the HOVON87/NMSG18 study

Claudia A.M. Stege (Speaker), Kongsgaard Nielsen, L. (Other), Birgit Witte (Other), Bronno van der Holt (Other), Ulf-Henrik Mellqvist (Other), Morten Salomo (Other), Gerard Bos (Other), Mark-David Levin (Guest lecturer), Heleen Visser-Wisselaar (Guest lecturer), Markus Hansson (Guest lecturer), Annette van der Velden (Guest lecturer), Wendy Deenik (Other), Astrid Gruber (Other), Juleon Coenen (Speaker), Plesner, T. (Speaker), Saskia Klein (Other), Bea Tanis (Other), Damian L. Szatkowski (Other), Rolf Brouwer (Other), Matthijs Westerman (Other), Rineke Leys (Other), Harm Sinnige (Other), Einar Haukås (Other), Klaas van der Hem (Other), Marc Durian (Other), Vera Mattijssen (Other), Peter Gimsing (Other), Niels van de Donk (Other), Marian Stevens-Kroef (Other), Pieter Sonneveld (Other), Anders Waage (Other), Sonja Zweegman (Other), Abildgaard , N. (Other)

Activity: Talks and presentationsConference presentations

Period22. Jun 201725. Jun 2017
Event typeConference
LocationMadrid, Spain